PRNP and prion disease: PrPC was identified as the key substrate that is converted to PrPSc in studies showing that the typical neurological dysfunction associated with prion disease did not develop when the PRNP was ablated and that prion disease could be generated by inoculation with recombinant PrP (rPrP) fibrils prepared in vitro [4,5,6].